Clinical Trial Update: Arterial Disease Multifactorial Intervention Trial (ADMIT) [Phase 3]

View source ↗

Summary

Completed Phase 3 clinical trial update for the Arterial Disease Multifactorial Intervention Trial (ADMIT) sponsored by the National Heart, Lung, and Blood Inst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Diseases
• Cardiovascular Diseases
• Diabetes Mellitus
• Heart Diseases
• Vascular Diseases

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arterial Occlusive Diseases, Cardiovascular Diseases | Phase 3 | Status: COMPLETED